|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|
| NON-CURRENT ASSETS | ||
| Property, plant and equipment | ||
| Right-of-use assets | ||
| Goodwill | ||
| Other intangible assets | ||
| Investment in a joint venture | ||
| Financial assets at fair value through profit or loss (“FVTPL”) | ||
| Deferred tax assets | ||
| Other non-current assets | ||
| Total non-current assets | ||
| CURRENT ASSETS | ||
| Inventories | ||
| Trade receivables, net | ||
| Prepayments, other receivables and other assets | ||
| Cash and bank balances | ||
| Total current assets | ||
| CURRENT LIABILITIES | ||
| Trade payables | ||
| Other payables and accruals | ||
| Contract liabilities | ||
| Interest-bearing bank and other borrowings | ||
| Total current liabilities | ||
| NET CURRENT ASSETS | ||
| TOTAL ASSETS LESS CURRENT LIABILITIES | ||
| NON-CURRENT LIABILITIES | ||
| Contract liabilities | ||
| Interest-bearing bank and other borrowings | ||
| Deferred tax liabilities | ||
| Deferred income | ||
| Other non-current liabilities | ||
| Total non-current liabilities | ||
| TOTAL LIABILITIES | ||
| EQUITY | ||
| Ordinary shares (par value of US$0.0001 per share as of December 31, 2024 and 2025; 315,224,993 and 373,321,692 shares authorized, issued and outstanding as of December 31, 2024 and 2025, respectively) | ||
| Treasury shares | ||
| Share premium | ||
| Capital and reserves | ||
| Exchange fluctuation reserve | ||
| Accumulated losses | ||
| Equity attributable to ordinary equity holders of the Company | ||
| Non-controlling interests | ||
| Total equity |
Loading...
